Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

First-in-Human Study of the GDF-15 Neutralizing Antibody CTL-002 in Patients With Advanced Cancer (GDFATHER) (GDFATHER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04725474
Recruitment Status : Recruiting
First Posted : January 26, 2021
Last Update Posted : September 28, 2021
Sponsor:
Information provided by (Responsible Party):
CatalYm GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 31, 2023
Estimated Study Completion Date : May 31, 2025